Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine.

[1]  J. Lang,et al.  Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines. , 2000, Acta tropica.

[2]  J. Lang,et al.  A new Vero cell rabies vaccine: results of a comparative trial with human diploid cell rabies vaccine in children. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  P. Arguin.  Human rabies prevention -- United States, 1999 : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1999 .

[4]  W. Haupt.  Rabies--risk of exposure and current trends in prevention of human cases. , 1999, Vaccine.

[5]  J. Lang,et al.  Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV). , 1998, Biologicals : journal of the International Association of Biological Standardization.

[6]  J. Lang,et al.  Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial). , 1998, Vaccine.

[7]  D. Fishbein,et al.  Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: a nationwide prospective study. , 1993, Vaccine.

[8]  R. E. Pacer,et al.  Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side effects following primary and booster pre-exposure immunizations. , 1989, Vaccine.

[9]  D. Frazier,et al.  The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine. , 1987, The Journal of allergy and clinical immunology.

[10]  C. Reed,et al.  IgE and IgG antibodies to beta-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine. , 1987, The Journal of infectious diseases.

[11]  A. Deutsch,et al.  Immune complex-like disease in 23 persons following a booster dose of rabies human diploid cell vaccine. , 1986, Vaccine.

[12]  C. Helmick,et al.  A clinical study of Merieux human rabies immune globulin. , 1982, Journal of biological standardization.

[13]  S. Plotkin,et al.  Development and clinical trials of the new human rabies vaccine of tissue culture (human diploid cell) origin. , 1978, Developments in biological standardization.

[14]  P. Yager,et al.  A rapid tissue culture test for determining rabies neutralizing antibody. , 1973, Monograph series. World Health Organization.